Plasma Testosterone and Testosterone Binding Affinities in Men with Impotence, Oligospermia, Azoospermia, and Hypogonadism DAPHNE M. LAWRENCE, G. I. M. SWYER British Medical Journal, 1974, 1, 349-351 Summary Mean plasma testosterone levels ( ± S.D.), using Sephadex LH-20 and competitive protein binding, were 629 + 160 ng/100 ml for a group of 27 normal adult men, 650 + 205 ng/100 ml for 27 impotent men with normal secondary sex characteristics, 644 + 178 ng/100 ml for 20 men with oligospermia, and 563 + 125 ng/100 ml for 16 azoospermic men. None of these values differ significantly. For 21 men with clinical evidence of hypogonadism the mean plasma testosterone (± S.D.), at 177 + 122 ng/100 ml, differed significantly (P <0 001) from that of the normal men.
The mean testosterone binding affinities (as measured by the reciprocal of the quantity of plasma needed to bind 50% of 3H-testosterone tracer) were similar for normal, impotent, and oligospermic men. Though lower for azoospermic men the difference was not significant (P >0 1). For 12 of the 16 hypogonadal males the testosterone binding affinity was normal, but raised binding affinities, similar to those found in normal adult females or prepubertal boys (about twice normal adult male levels), were found in four cases of delayed puberty. These findings help to explain why androgen therapy is usually useless in the treatment of impotence. (Lawrence and Swyer, 1973) .
Introduction

Materials and Methods
Blood was drawn into heparinized tubes between 09.30 and 12.00 and between 13.30 and 16.00 hours from both the patients and the normal controls. The significance of a circadian rhythm in testosterone levels with higher values expected in the morning and lower levels in the late afternoon was appreciated but it is believed that the scatter of times of venesection was similar for all the groups of men studied. The plasma testosterone was extracted after separation on short columns (13 by 0-7 cm) of Sephadex LH-20 and measured by competitive protein binding using ammonium sulphate precipitation of the bound testosterone. The method used was that of Lawrence and Swyer (1973) as modified from those of Murphy (1970) and Mayes and Nugent (1968) .
Testosterone binding affinity was measured by the method of August et al. (1969) . In this method testosterone affinity is expressed as 1/S, the reciprocal of the quantity of plasma needed to bind 50% of 05 ng of 1,2 3H-testosterone (specific activity 40-45 Ci/mmol). Florisil was used to remove the unbound testosterone.
Results
The plasma testosterone levels in the 27 normal males ranged from 408 to 1,022 ng/100 ml (mean (+ S.D.) 629 + 160). The range for the 27 impotent men was 352 to 1,147 ng/100 ml (mean 650 + 205). The 20 men with oligospermia had values of 368 to 1,060 ng/100 ml (mean 644 + 178), and the 18 men with azoospermia 365 to 766 ng/100 ml (mean 563 + 125). The range for the group of 21 men with hypogonadism was 30 to 378 ng/100 ml (mean 177 + 122).
The individual results are plotted in fig. 1 . Though the scatter was greater in the impotent group the difference between the mean values of this and the normal group was not significant (P >0-7). Similarly, the mean value for the men with oligospermia was not significantly different from that of the normal group though the mean value for the azoospermic group was lower, but again the difference was not statistically significant (P>0-1). On the other hand, for the hypogonadal group the mean plasma testosterone value was highly significantly lower than that of the normal group (P <0001). The mean testosterone binding affinity of the normal men did not differ significantly from that of the oligospermic men (P >0-6), the impotent men (P >0 3), or the azoospermic men (P >0 1). The hypogonadal group had a higher mean binding affinity in comparison with that of the normal men but this'was due to four of the 16 subjects aged 15 to 19 with delayed puberty whose values were similar to those of our normal female subjects. These have nearly double the binding capacity of adult males and the same has been found in prepubertal male children by August et al. (1969) . The individual results are plotted in fig. 2 together with 14 values for normal female subjects.
Conclusion
The finding that there was no deficiency of plasma testosterone in a group of impotent but otherwise normal men helps to explain why androgen therapy is usually unsuccessful in the treatment of impotence. Three of the present cases had previously been treated with testosterone oenanthate by injection or fluoxymesterone by mouth and had not shown improvement. Intramuscular injections of testosterone-oenanthate 250 mg can markedly raise plasma testosterone-for example, up to 2,000 ng/100 ml testosterone seven days after injection-yet in spite of these high levels impotent males generally obtain little or no benefit-in striking contrast to hypogonadal males.
We have not attempted to explain the discrepancy between our findings of normal plasma testosterone and the low urinary testosterone reported by other workers. Ansari et al. (1973) reported reduced urinary testosterone excretion in impotent patients but, like us, they found normal plasma testosterone levels. They also reported a raised luteinizing hormone concentration and a reduced oestrogen excretion. One of our patients (case 27) aged 62 has been treated with oestrogen and showed some response. Teter (1972) claimed that mixed oestrogen and androgen therapy gives better results in selected cases of the so-called male climacteric with impotence than testosterone alone.
Our data on plasma testosterone in oligospermia and azoospermia confirm the findings of Rosen and Weintraub (1971) . We also find that the testosterone binding affinities in these groups are normal.
It is noteworthy that the older but not the younger hypogonadal males have normal adult male testosterone binding affinities in spite of their low plasma testosterone levels. Why adult men, whether normal or hypogonadal, have lower testosterone binding affinities than women and prepubertal boys remains obscure.
